Theralase Technologies Inc (TLTFF)

[chambers]

Right now the Company is currently working on an orthotopic in-vivo rat model, where they are actually inducing bladder cancer.

We should be getting the results from that testing over the new few weeks, and then the following needs to be accomplished before Phase 1/2a human trials can start:

- GMP needs to be tested in a pharmaceutical environment
- Toxicity analysis
- The Clinical Protocol needs to be written
- Drug Master File assembled

So Theralase still needs to complete a bit of work, but in the mean time we will still be getting some results from the lab, and regular updates on the how final production / rollout of the TLC-2000 is going.